Clinical trials
Recruiting Huntington Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| CHDI Foundation, Inc. | 1 |
| King's College London | 1 |
| Novartis Pharmaceuticals | 1 |
| Prilenia | 1 |
| Sarepta Therapeutics, Inc. | 1 |
| Skyhawk Therapeutics, Inc. | 1 |
| University College, London | 1 |
| Vico Therapeutics B. V. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huntington Disease | 9 |
| Machado-Joseph Disease | 1 |
| Neurodegenerative Diseases | 1 |
| Spinocerebellar Ataxias | 1 |
| Spinocerebellar Degenerations | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.